Increased expression and glycosylation of EMMPRIN positively correlate with metastasis in several cancer types including prostate cancer (Egawa et al., 2006; Koga et al., 2007; Riethdorf et al., 2006; Zhu et al., 2012). This evidence concerns the gene BSG and prostate cancer.